| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12032-014-0047-Z |
| P698 | PubMed publication ID | 24913811 |
| P2093 | author name string | A Quessar | |
| H Dehbi | |||
| S Benchekroun | |||
| S Nadifi | |||
| M Quachouh | |||
| Y Kassogue | |||
| P2860 | cites work | Functional polymorphism of CYP2B6 G15631T is associated with hematologic and cytogenetic response in chronic myeloid leukemia patients treated with imatinib | Q39123115 |
| Glutathione and related enzymes in multidrug resistance | Q41078132 | ||
| GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization | Q42779094 | ||
| Nomenclature for human glutathione transferases | Q42793315 | ||
| Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia | Q42906748 | ||
| Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia | Q44031695 | ||
| Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia | Q44155345 | ||
| Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis | Q44353700 | ||
| Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. | Q46558722 | ||
| Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy. | Q46659117 | ||
| Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. | Q48053370 | ||
| Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach | Q58010946 | ||
| Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study | Q73426872 | ||
| ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib | Q82767554 | ||
| Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis | Q23922953 | ||
| Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13 | Q24671518 | ||
| A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 | ||
| Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1) | Q28277107 | ||
| Dynamics of resistance development to imatinib under increasing selection pressure: a combination of mathematical models and in vitro data | Q28478542 | ||
| Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia | Q29614280 | ||
| Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data | Q30885947 | ||
| The molecular biology of chronic myeloid leukemia. | Q34079452 | ||
| Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia | Q34183674 | ||
| The glutathione S-transferases: an update | Q34497816 | ||
| BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia | Q34651708 | ||
| Practical management of patients with chronic myeloid leukemia receiving imatinib | Q35095956 | ||
| Glutathione S-transferase polymorphisms: cancer incidence and therapy | Q36426775 | ||
| Strategies to circumvent the T315I gatekeeper mutation in the Bcr-Abl tyrosine kinase | Q37104343 | ||
| Glutathione Transferase (GST)-Activated Prodrugs. | Q37327903 | ||
| Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer | Q38459487 | ||
| P433 | issue | 7 | |
| P921 | main subject | chronic myeloid leukemia | Q729735 |
| P304 | page(s) | 47 | |
| P577 | publication date | 2014-06-10 | |
| P1433 | published in | Medical Oncology | Q2152666 |
| P1476 | title | Effect of interaction of glutathione S-transferases (T1 and M1) on the hematologic and cytogenetic responses in chronic myeloid leukemia patients treated with imatinib | |
| P478 | volume | 31 |
| Q41144255 | Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia |
| Q50125287 | GSTT1 and GSTM1 null variants in Mestizo and Amerindian populations from northwestern Mexico and a literature review. |
| Q43180336 | Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients |
| Q90435544 | Glutathione S-transferase M1 and T1 genes deletion polymorphisms and risk of developing essential hypertension: a case-control study in Burkina Faso population (West Africa) |
| Q42068319 | Glutathione-s-transferase A 4 (GSTA4) suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting AKT pathway |
| Q92182769 | Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response |
| Q58585276 | KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia |
Search more.